Learning Objectives:

1. Verbalize the prevalence and outcomes of tricuspid regurgitation

2. Articulate the general approach to tricuspid valve treatment

3. Describe ongoing trials evaluating new treatments of tricuspid regurgitation

Session date: 
11/13/2020 - 8:00am to 9:00am CST
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Mark Ricciardi, MD